ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,482Medicare Part D Prescriptions Filled, Including Refills

Rank: 178 out of 387

$308K Total Retail Price of All Prescriptions

Rank: 229 out of 387

290 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,675 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
POTASSIUM CHLORIDE 228 194 1 9
TAMSULOSIN HCL 210 199 2 32
SIMVASTATIN 184 147 3 5
METFORMIN HCL 183 165 4 8
LEVOTHYROXINE SODIUM 174 163 5 2
GABAPENTIN 172 129 6 10
HYDROCODONE-ACETAMINOPHEN 171 148 S3 7 1
OMEPRAZOLE 167 163 8 4
AMLODIPINE BESYLATE 156 141 9 6
MELOXICAM 139 117 10 22
LISINOPRIL 130 88 11 3
FUROSEMIDE 127 115 12 7
FAMOTIDINE 117 93 13 78
FLUOXETINE HCL 108 95 14 46
DONEPEZIL HCL 99 99 15 27
PRAVASTATIN SODIUM 90 90 16 15
COUMADIN 79 79 17 239
POLYETHYLENE GLYCOL 3350 74 74 18 57
ATENOLOL 74 74 18 20
CLOPIDOGREL 70 57 20 25
ALLOPURINOL 69 58 21 28
BUMETANIDE 68 68 22 247
LANTUS 67 63 23 51
WARFARIN SODIUM 65 65 24 17
SUCRALFATE 63 62 25 128
ZOLPIDEM TARTRATE 61 52 26 16
TRAMADOL HCL 61 58 26 14
TRAZODONE HCL 60 40 28 37
RANITIDINE HCL 59 28 29 45
METOPROLOL SUCCINATE 56 56 30 18
ROPINIROLE HCL 56 49 30 91
AMLODIPINE BESYLATE-BENAZEPRIL 55 48 32 54
PLAVIX 54 44 33 39
CYMBALTA 53 37 34 44
METOPROLOL TARTRATE 51 28 35 11
CARVEDILOL 50 45 36 21
CIPROFLOXACIN HCL 50 44 36 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.